To date, several COX-2-selective inhibitors (coxibs) that have been used for the treatment of arthritis, post-operative pain, headaches, and inflammatory diseases of the brain and peripheral tissues have been developed [116]. Here, PTGS2 is linked to arthritic joint disease.